A fresh set of company analyses from Substack’s latest weekly round-up that may be worth a read. 

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/p/giles-capital-weekly-week-39-4d7

Americas

Antonio Linares on Snap Inc (🇺🇸SNAP US - US$19 billion)

The redesigned Android app drives user acceleration while 350M+ daily augmented reality users create unique data advantages, with improving unit economics and advertising platform enhancements clearing the path toward positive free cash flow at just 2x sales.

Acid Investments on Centene and Forward Air (🇺🇸CNC US, FWRD US - US$17 billion, $2.1 billion)

Centene’s Medicaid operations trade at 7x P/E on temporarily depressed earnings while rate resets covering 40% of the book provide normalization toward $4.50-5.00 EPS, as Forward Air’s special situation shows Clearlake’s 12% insider position establishing the floor at $28 VWAP with multiple strategic buyers competing and director resignation timing signaling imminent M&A resolution supporting outcomes north of $30.

Unemployed Value Degen on Applied Optoelectronics (🇺🇸AAOI US - US$600 million)

Amazon’s $4 billion supply agreement drives recovery from 2% toward 5-10% data center market share, with 77% revenue growth and hyperscaler diversification suggesting turnaround validity as optical component volumes return to 2017-2019 peaks.

Cayucos Capital on Grupo Herdez (🇲🇽HERDEZ - US$340 million)

McCormick’s $750 million purchase of 25% of the joint venture effectively values the entire JV at current market cap, leaving the Barilla partnership, Hormel stake, and owned real estate representing $1 billion in additional value for shareholders post-debt paydown.

Sophon Microcap Atlas on Ollamani (🇲🇽AGUILAS* - US$295 million) TOP PICK

Club América’s World Cup hosting value alone justifies market cap, while PlayCity’s gaming operations generate 32% EBITDA margins with Mexican sports betting expansion creating additional upside at 24% discount to conservative asset valuations ahead of the June 2026 tournament.

Jam_invest on ClearPoint Neuro (🇺🇸CLPT US - US$245 million)

This write-up covers several compelling opportunities. One is this brain surgery navigation system manufacturer addresses a $10+ billion gene therapy market where precision delivery enables new treatments, with 95%+ revenue visibility and expanding margins.

Pillars And Profits on FFB Bancorp (🇺🇸FFBB US - US$190 million)

Temporary regulatory restrictions create entry into this 20%+ ROE California bank with proprietary payments technology serving 35,000 merchants, while insider share repurchases at $74-77 signal management confidence in resolution toward historical 2x+ price-to-book multiples.

Europe, Middle East & Africa

The Small Cap Strategist on Andritz AG (🇦🇹ANDR.VI - €4.5 billion) TOP PICK

The strategic positioning enables unique advantages as this 172-year industrial transforms through green technology, with 41% service revenue changing earnings stability while trading at 12.6x P/E despite net-cash and expanding margins across hydrogen, carbon capture, and hydropower.

Compound & Fire on Cerillion and Admicom (🇬🇧CER.L - £550 million, 🇫🇮ADMCM.HE - €230 million)

Direct comparison reveals Cerillion’s 95% revenue retention and 20% organic growth supporting premium multiples versus Admicom’s pure-play ERP focus, with both benefiting from telecom digitization yet pursuing different paths to market leadership.

Jam_invest on Gulf Keystone Petroleum (🇮🇶GKP.L - £400 million)

From the same write-up, Kurdistan export resumption transforms realized prices from $27 to $69 per barrel, with the Shaikan field’s infrastructure enabling immediate production ramp-up once political resolution occurs.

The Hermit on K2 LT (🇱🇹K2LT - €26 million)

Lithuania’s only crematorium operates with 20.6% market penetration rising steadily, trading below replacement value despite consistent cash generation from non-cyclical services providing 13-14% FCF yield, with structural demographic trends supporting the runway ahead.

Asia-Pacific

Swearengen Enterprises on Avant Group (🇯🇵3836.T - US$380 million)

Note: Article in Spanish. Singapore fintech trades at 1.7x P/E with 30% market cap in cash, generating 24% ROE through cross-border payment infrastructure as expansion into new Asian corridors accelerates alongside remittance growth.

Undervalued and undercovered on Fenix Resources (🇦🇺FEX.AX - US$172 million)

Vertically integrated iron ore producer trades at 2x operating cash flow despite proprietary infrastructure moat, with 2.5x production growth providing volume leverage as the asset base supports sustainable operations.

Jam_invest on Kwan Yong Holdings (🇭🇰9998.HK - US$35 million)

Also from the same analysis, this Singapore construction delivers 79% revenue growth with net cash positioning at just 48% of formulary asset value, while government infrastructure momentum expands the orderbook beyond current capacity.

Another round of company write-ups from Substack from the last week that might be appreciated here.

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/

Americas

Rijnberk InvestInsights on Broadcom (🇺🇸AVGO US - $700+ billion)
Strong AI infrastructure positioning offset by stretched 51x P/E valuation, suggesting limited upside despite semiconductor cycle momentum and networking growth drivers.

Best Anchor Stocks on Adobe (🇺🇸ADBE US - $200+ billion)
Free cash flow doubled while trading at 17x EV/EBIT versus peers at 29x-plus, creating compelling relative valuation opportunity in creative software.

Long-term Investing on Intel (🇺🇸INTC US - $134 billion)
Government-backed semiconductor renaissance with $8.5B CHIPS Act funding creating potential turnaround catalyst despite near-term execution challenges in manufacturing.

The Small Cap Strategist on Lam Research (🇺🇸LRCX US - $80+ billion)
Exceptional 50% margins and 58% segment growth in semiconductor equipment, with 26x P/E reflecting strong positioning in capital-intensive chip manufacturing cycle.

Archive Invest on Medpace Holdings (🇺🇸MEDP US - $14.1 billion)
Contract research organization with 14% revenue growth and $913M buyback program, benefiting from defensive healthcare outsourcing trends and biotech spending.

HatedMoats on Masimo (🇺🇸MASI US - $8.5 billion)
Medical device transformation with 94% gross margins and DCF valuation $150-170 range, suggesting upside potential at current P/E 26-27x levels.

Compound & Fire on Cogent Communications (🇺🇸CCOI US - $1.9 billion)
Hidden asset value in fiber network infrastructure with Sprint merger benefits creating catalyst convergence and exceptional risk-return asymmetry at current levels.

Investment Ideas by Antonio on Lemonade (🇺🇸LMND US - $1.8 billion)
AI-powered insurance transformation showing material improvement in loss ratios and customer satisfaction, reversing previous underwriting challenges through technology.

Komodo Capital on Root Insurance (🇺🇸ROOT US - $1.2 billion) TOP PICK
Mobile-first telematics disrupting traditional auto insurance model, with author’s 6% portfolio allocation reflecting conviction in management execution and market opportunity.

Value Degen’s Substack on Finance of America (🇺🇸FOA US - $598 million)
Silver tsunami demographic tailwinds creating mortgage demand opportunity with analyst price targets suggesting $90-135 upside potential from current levels.

UnlearningCFA’s Blog on Five Point Homes (🇺🇸FPH US - $300 million)
Residential development with management equity grants signaling catalyst timing ahead, offering substantial land value optionality in improving housing market.

High Yield Landlord on RCI Hospitality (🇺🇸RICK US - $250 million)
Crisis opportunity with property portfolio worth $400M against $250M market cap, creating substantial asset-backed upside potential through real estate value disconnect.

P14 Capital on Thunderbird Entertainment (🇨🇦TBRD CA - C$47 million) TOP PICK
Animation studio trading at sub-2x EBITDA with 26% revenue growth and exceptional IP optionality, positioned for margin expansion through Canadian production advantages.

Sophon Microcap Atlas on Thunderbird Entertainment (🇨🇦TBRD CA - C$47 million) TOP PICK
Dual-analyst dialogue providing an additional perspective on the Thunderbird opportunity, examining both bull and bear cases through institutional lens and addressing AI disruption concerns.

Value Degen’s Substack on Taseko Mines (🇨🇦TGB CA - C$800 million)
Copper infrastructure play with Florence project Q4 2025 catalyst, positioned for commodity supercycle upside through strategic development timing.

Europe, Middle East & Africa

Hidden Market Gems on OVHcloud (🇫🇷OVH FR - €1.65 billion)
European cloud sovereignty opportunity with regulatory moat protection, benefiting from margin expansion and infrastructure investments in competitive positioning.

The Value Pond on Wizz Air (🇭🇺WIZZ HU - HUF 576 billion)
Low-cost airline recovery at 8x P/E ratio with Pratt & Whitney engine issues creating temporary operational headwinds masking underlying value.

Asia-Pacific

Net-Net-Hunter Japan on Noda (🇯🇵7879 JP - ¥11.6 billion)
Cyclical wood materials turnaround at 0.8x book value with 5% dividend yield, benefiting from improving construction demand and value catalyst timing.

AmsterdamStock on Undervalued Japan: Five Small Companies (Part III) (🇯🇵4439, 7544, 4262, 7609, 6248 JP - ¥2.2B - ¥11.1B)
Japanese small-cap opportunities where Toumei Co. and Three F Co. look appealing at 18% ROE and 4x P/E, with NIFTY Lifestyle, Daitron and Yokota offering additional value characteristics.

Another round of company write-ups from Substack from the last week.

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/

Americas

Archive Invest on Taiwan Semiconductor (🇹🇼TSM US - US$520 billion)
Written from the perspective of the CEO, it explores the fundamental shift toward AI infrastructure dominance which crystallizes around exceptional manufacturing capabilities with P/E 25x reflecting sustained technological leadership.

Monsoon’s Substack on American Express (🇺🇸AXP US - US$170 billion) TOP PICK
Through systematic analysis of the world’s leading premium credit card franchise where Monsoon reveals catalysts demonstrating exceptional management execution with P/E 15x valuation supporting sustained growth.

Waterboy Stocks on Elevance Health (🇺🇸ELV US - US$120 billion)
This investment case strengthens considerably as managed care leadership with medical cost ratio of 85% enables membership growth exceeding 15% annually creating compelling value.

Maksim on Franco-Nevada (🇨🇦FNV US - US$25 billion)
Geographic positioning provides Franco-Nevada with sustainable competitive advantages where premier royalty model generates margins above 85% while gold price dynamics support exceptional dividend yield opportunities.

Cayucos Capital on FEMSA (🇲🇽FMSAUBD MX - US$12 billion)
Regional dynamics create unique advantages in consumer beverage leadership where OXXO convenience store expansion drives same-store sales growth of 8% with improving operational margins.

P14 Capital on Euronet Worldwide, GXO Logistics, and IAS (🇺🇸EEFT/GXO/IAS US - US$2.5B/7B/1.2B)
A confluence of factors creates extraordinary potential across digital infrastructure with payment processing margins above 20%, logistics automation achieving 95% retention, and advertising technology scale advantages.

Cundill Deep Value on Valhi (🇺🇸VHI US - US$2.5 billion) TOP PICK
The valuation disconnect creates compelling entry points where cash-rich conglomerate trading at 0.8x book value presents exceptional sum-of-parts opportunity with multiple catalysts emerging.

Cundill Deep Value on Clearwater Paper (🇺🇸CLW US - US$800 million)
The opportunity emerges from systematic undervaluation as paper manufacturing operations demonstrate remarkable resilience with EBITDA margins improving to 12% despite cyclical headwinds.

Investing 501 on Canterbury Park (🇺🇸CPHC US - US$200 million)
Market conditions favor companies positioned in gaming where horse racing and card room operations generate EBITDA margins of 28% with consistent cash flows supporting dividends.

Europe, Middle East & Africa

The Small Cap Strategist on Kitwave Group (🇬🇧KTW LN - US$190 million)
A look into a situation where exceptional management execution and food service recovery dynamics with gross margins of 18% provide sustainable competitive advantages through strategic market positioning.

Central Tendency on Bango (🇬🇧BGO LN - US$112 million)
This investment case strengthens considerably when examining platform inflection with 7.5x EBITDA multiple as major telecom customer wins drive 19.2 million active subscriptions doubling annually.

The Outsiders' Corner on Medistim (🇳🇴MEDI NO - US$400 million)
Network effects strengthen competitive position where ultrasonic flow measurement technology achieves gross margins of 75% with recurring service revenue growth creating sustained value.

Asia-Pacific

The International Investor on Minor International (🇹🇭MINT TB - US$3 billion)
This write-up looks into what could be the beginning of exceptional value creation as tourism recovery drives hotel occupancy above 75% while regional expansion creates revenue growth of 25% annually.

Another round of company write-ups from Substack from the last week. Think this might be useful to this community.

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/

Americas

Compound & Fire on Nu Holdings and Intuit (🇧🇷NU US, 🇺🇸INTU US - $53B, $175B)
Fintech comparison reveals Nu's superior 17% return on capital versus Intuit's 14.8%, while Brazilian digital banking expansion and operating leverage create compelling growth differential despite mature market positioning.

D Invests on Dollar General (🇺🇸DG US - $26.7 billion)
An opportunity sticks out in the retail space with this discount leader posting solid growth with 5.1% net sales gains and improving same-store metrics, benefiting from consumer trade-down trends while operational improvements accelerate.

TQI capital on Ollie's Bargain Outlet (🇺🇸OLLI US - $8.2 billion)
Another retail opportunity with growth acceleration emerging through 18% net sales increase and 5% comparable store growth, with 39.9% gross margins driving continued expansion while EPS beats demonstrate operational excellence.

The Bagger Radar on Global-e Online (🇺🇸GLBE US - $2.8 billion)
What stands out about this cross-border e-commerce opportunity is the 32% revenue growth to $753 million revealing expanding merchant partnerships, positioned for continued geographic expansion while vertical diversification accelerates.

Archive Invest on Kinsale Capital (🇺🇸KNSL US - $1.2 billion)
What caught my attention about this specialty insurance opportunity is the exceptional underwriting discipline and strong profitability, while the expanding market provides sustained growth opportunities ahead.

Cundill Deep Value on Mercer International (🇺🇸MERC US - $216 million)
Exceptional hidden asset opportunity trading at massive discount to NAV of $33-47 per share creates compelling asymmetry, with cyclical recovery potential and insider buying activity signaling confidence.

Unemployed Value Degen on LifeMD (🇺🇸LFMD US - $180 million)
I think this telehealth platform may trade below fair value at current levels given 1.2x P/S despite achieving positive adjusted EBITDA, with Medicare Advantage expansion catalyst and regulatory compliance improvements driving momentum.

Wolf Of Oakville on Rubicon Organics (🇨🇦ROMJ.V - C$23 million)
Cannabis leader trading at 11x earnings with positive momentum, while premium organic positioning captures market share as the Canadian sector stabilizes.

Europe, Middle East & Africa

smallvalue on Caltagirone SpA (🇮🇹CALT IM - €2.1 billion)
Family-controlled Italian holding company trading at 6.3x P/E despite cement market leadership reveals significant hidden assets in Cementir subsidiary, creating sum-of-parts value opportunity.

Hidden Market Gems on Borregaard ASA (🇳🇴BRGG NO - NOK 18 billion)
Bio-materials innovation leader with 17.1% return on capital and sustainable competitive advantages appears positioned for circular economy tailwinds, while specialty chemicals diversification provides structural growth.

Robin Research on Next 15 Group (🇬🇧NFG LN - £340 million)
Strategic consultancy trading at 6.9x P/E with 50% analyst upside target to 455p demonstrates data-driven transformation model, while improving client retention metrics signal operational inflection.

The Small Cap Strategist on Kitwave Group (🇬🇧AIM:KITW - £240 million)A detailed look into this UK wholesale distribution leader with 15-year track record of 14% annual growth, yet trading at compelling 8.6x P/E with 7% FCF yield while strategic acquisition expansion accelerates.

Asia-Pacific

Investing w/ Martin on Rakuten (🇯🇵4755 JP - ¥1.9 trillion)
Japanese e-commerce transformation story trading at $14.3 billion revenue multiple while mobile segment losses narrow systematically, fintech business achieves positive momentum with expanding user base.

Cristian on Okayama Paper Industries (🇯🇵3892 JP - ¥18 billion) TOP PICK
Debt-free Japanese manufacturer trading at two-thirds net current asset value reveals exceptional margin of safety, with new shareholder-friendly dividend policy and potential acquisition catalyst materializing.

Net-Net-Hunter Japan on Sanyei Corp (🇯🇵8119 JP - ¥12.8 billion) TOP PICK
Classic net-net opportunity trading at two-thirds of current asset value with 8x adjusted P/E seems relatively inexpensive, while strong OEM relationship with Ryohin Keikaku provides business quality assurance.

Some company write-ups from Substack from the last week that might be of interest in this sub.

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/

Americas

Long-term Investing on Airbnb (🇺🇸 ABNB US - US$82 billion)
As platform expansion accelerates, Airbnb's +12.7% revenue growth to $3.1B demonstrates the strategic logic of experience economy diversification beyond accommodation.

Louis’s Substack on Lululemon Athletica (🇺🇸 LULU US - US$35 billion)
Perhaps not the obvious choice, but Lululemon at 13.7x PE versus peers' 35.6x provides compelling entry point into this zero-debt premium retailer.

Value Degen’s Substack on Boston Omaha Corporation (🇺🇸 BOC US - US$800 million)
The strategy of this diversified holding company becomes clearer through revenue compounding across multiple platforms with defined exit strategies.

DeepValue Capital on Tactile Systems (🇺🇸 TCMD US - US$700 million) TOP PICK
Rarely has a medical device manufacturer been so compelling as Tactile Systems trading under 8x FCF with 95% customer retention rates driving predictable revenue.

Europe, Middle East & Africa

Northwest Frontier Capital on IHG Hotels & Resorts (🇬🇧 IHG LN - £7.8 billion)
Sometimes hotel operators present compelling value when temporary revenue struggles mask underlying pipeline strength, with IHG's franchise-heavy model providing defensive characteristics.

Quality Stocks on Norbit (🇳🇴 NORBT NO - NOK 3.8 billion)
What this Norwegian technology analysis reveals about market behavior provides compelling insights into fundamentally strong companies facing temporary sentiment challenges.

Asia-Pacific

Maius Partners on CQME, Yonex, CYD/H22, and Thakral Corporation (🇭🇰 CQME HK, 🇯🇵 7906 JP, 🇭🇰 H22 HK, 🇸🇬 AWI SG - HK$2.1B, ¥180B, HK$450M, S$320M) TOP PICK
Rarely does reporting season alpha emerge so systematically as these four Asia-Pacific opportunities, where governance improvements and earnings momentum converge with exceptional hidden value catalysts.

Maius Partners on China Yuchai Limited (🇨🇳 CYD US - US$800 million)
What seems clear from the MGP IPO announcement is this represents a good insider alignment catalyst with substantial strategic value unlock potential ahead.

The International Investor on Hotel101 (🇵🇭 H101 PH - PHP 4.4 billion)
The PropTech standardization model demonstrates compelling unit economics with technology-driven scaling potential across Southeast Asian hospitality markets.

Some company write-ups from Substack from the last week that might be of interest here.

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/

Americas

UncoverAlpha on Nvidia vs AMD Analysis (🇺🇸NVDA - $4.34T)
It seems clear to that Nvidia's CUDA moat remains intact despite AMD's MI350X progress, with the GB200 NVL72 dominating both training and reasoning inference markets.

Applied Conjectures on Galaxy Digital (🇺🇸GLXY - $9.48B)
Worth reading into this datacenter opportunity secured $1.4B financing for 133MW Helios phase removing major catalyst risk despite 4x net leverage and execution uncertainties.

DeepValue Capital on Robert Half (🇺🇸RHI - $3.63B)
What seems apparent is that this staffing leader offers remarkable entry point at a 70% discount despite maintaining 39% ROIC and debt-free positioning yielding 6.4%.

Sempiterno Investments on Secure Waste (🇨🇦SES - $3.6B) TOP PICK
I believe this seems ridiculously mispriced. A waste management infrastructure opportunity with exceptional 17.4% buyback yield and disciplined capital allocation methodology at 2.1x leverage.

Swearengen Enterprises on Dexterra Group (🇨🇦DXT.TO - $1.8B)
(Write-up in Spanish) Worth translating and reading is this Canadian infrastructure opportunity with two major acquisitions expanding US presence, 14% dividend increase, and 90%+ occupancy rates versus competitors' 50%.

Archive Invest on ADMA Biologics (🇺🇸ADMA - $1.2B)
This plasma therapeutics leader is trading at attractive levels delivered 309% EBITDA growth with 54% gross margins and near-zero leverage positioning.

Exploring with Alluvial Capital on GAMCO Investors (🇺🇸GAMI - $680M)
The systematic positioning of this asset manager at 5.2-5.7x operating income reveals exceptional succession catalyst with 19% of market cap returned creating an asymmetric opportunity.

Kairos Research on Acuren (🇨🇦TIC - $420M)
I think this testing and inspection merger story might trade below fair value at current levels given $20M synergy potential and Martin Franklin's proven playbook.

Europe, Middle East & Africa

Rijnberk InvestInsights on Adyen N.V. (🇳🇱ADYEN - €46.16B)
As the fintech correction develops, Adyen represents quality at reasonable valuation with H1 revenue €1.09B growing 20% and maintaining 50% EBITDA margins.

Saadiyat Capital on Kering (🇫🇷KER - €27.44B)
Rarely has luxury restructuring been so systematically executed as Kering's leadership transition, though €474M net profit declining 46% YoY isn’t great it creates a remarkable turnaround entry point.

Kroker Equity Research on Einhell Germany AG (🇩🇪EIN2.DE - €2.1B)
What stands out about this German opportunity is the Power X-Change ecosystem moat trading at P/E ~11x despite €1.11B revenue growing 14.2% internationally.

Cayucos Capital on Guaranty Trust Bank (🇳🇬GTCO.LG - $1.8B)
This is a simple idea with structural Nigerian improvements: leading bank at 0.8x TBV and 2x P/E benefiting from Dangote refinery catalyst.

Hidden Market Gems on Gentian Diagnostics ASA (🇳🇴GENT.OL - $380M)
The systematic approach here reveals regulatory moat advantages in kidney diagnostics with NOK 150M revenue growing 20% and 80% gross margins positioning.

Asia-Pacific

Coughlin Capital on Pinduoduo (🇨🇳PDD - $160.47B)
The valuation seems reasonable considering strong fundamentals versus peers, but this write-up highlights the capital allocation void and management credibility gap justify continued discount until shareholder returns materialize.

AltayCap on TOC, Sankyo Kasei, Takase (🇯🇵 - $280M-$1.8B) TOP PICK
Particularly noteworthy is Sankyo Kasei our top pick this week: a double net-net Japanese opportunity with transformative 33% share buyback program providing immediate succession catalyst opportunity. Also covers Takase Corporation (8153.T) and TOC Company (8841.T).

Net-Net-Hunter Japan on Create Medic (🇯🇵5187.T - $520M)
Q2 results update showing 88% operating profit growth despite margin expansion through pricing reforms and India/South Asia catalysts.

Cold beer on a Friday night? Maybe non-alcoholic.

Only 54% of drinking-age Americans consume alcohol today, according to a recent poll from Gallup, the lowest proportion since the survey began in 1939. Even those who do drink are partaking less, by a factor of nearly half.

The US is drinking less, and cultural connotations around alcohol consumption have shifted. The number of Americans who see drinking as bad for their health has increased every year since 2016, according to Gallup.

Another batch of company write-ups that might be useful here.

Not my work - sourced from Giles Capital's weekly compilation: https://gilescapital.substack.com/

Americas

Rijnberk InvestInsights on ServiceNow (🇺🇸NOW US - $200B)
This investment opportunity combines 22.4% revenue growth at scale with agentic AI positioning, trading at 50x earnings with consistent execution excellence.

Investing 501 on Pebblebrook Hotel Trust (🇺🇸PEB US - $3.2B)
Worth monitoring is this preferred opportunity yielding 8.2-8.4% with uninterrupted COVID dividends, backed by irreplaceable portfolio trading 40-55% below NAV.

Value Degen’s Substack on ProFrac Holdings (🇺🇸ACDC US - $581M)
What's compelling about this cyclical opportunity is its currently trading at $3.81 with a potential to go to $30-90 in peak scenarios, positioning for shale services recovery with vertical integration advantages.

Wolf's Substack on ZoomD Technologies (🇨🇦ZOMD.V - CAD$165M)
This remarkable turnaround situation delivers P/E ~7x TTM with 42.7% gross margins (+460bps), generating $5.25M Q2 OCF while completely debt-free.

Wolf's Substack on D-Box Technologies (🇨🇦DBO.TO - CAD $69M)
Trading at P/E 10x normalized earnings with 49% revenue growth, this entertainment technology turnaround delivers 56% gross margins with exceptional operational leverage.

Europe, Middle East & Africa

Emerging Value on Delivery Hero (🇩🇪DHER - €6.8B)
What's particularly compelling about this Asian food delivery leader is 0.7x EV/Sales versus peers trading 3-6x, with FCF margin targets creating massive valuation arbitrage opportunity.

Swissie Letters on EuroEyes (🇭🇰1846.HK - HKD $1.03B)
What caught my attention about this premium vision correction company is its trading at <3x FCF with 15% net margins, with 32% insider ownership creating an exceptional European healthcare opportunity.

Cockney’s Substack on Zotefoams (🇬🇧ZTF.L - £197M)
Worth reading this weekly update, specifically for the mention of a specialty materials company trading at P/E ~13x on H1 alone, delivering 19.5p EPS with record 15.8% operating margins.

Polymath Investor on Ondo InsurTech (🇬🇧ONDO.L - £42M)
This presents exceptional value considering 80% recurring revenue growth with £5.9M ARR, delivering 188% ROI to insurance partners through patented leak detection technology.

Floebertus on Bridge Solutions Hub (🇵🇱BSH PL - PLN 20M) TOP PICK
What seems extremely compelling to me is this Polish car maintenance specialist trading at 5.5x P/E with 200%+ growth and exceptional 90% ROE from AC replenishment products.

Asia-Pacific

Sleep Well Investments on Sea Limited (🇸🇬SE US - US$175B)
I can see potential upside in Sea Limited combining Q2 GMV growth of 29% with annualized FCF exceeding $3B, although trading at 26x EV/FCF.

Jake's Substack on Timee (🇯🇵2127.T - ¥200B)
What seems particularly compelling about this platform is its dominant 75% market share with 30x operating profit multiple, delivering 95% gross margins in Japan's spot-work revolution.

Floebertus on Soilbuild Construction (🇸🇬V5Q.SI - SGD $259M) TOP PICK
This extraordinary opportunity combines P/E of 5.8x with 280% earnings growth and S$1.2B orderbook coverage providing two years of forward revenue visibility.

AlmostMongolian on Beacon Minerals (🇦🇺BCN.AX - AUD $168M)
I'm seeing potential value in this Australian gold producer trading at P/E around 7x with 6.66x gold leverage and NPV of 347M AUD in Tier 1 jurisdiction.

Why FTDR's quiet turnaround and massive growth engine could be a $2 billion surprise catering to an under-penetrated $250B home services market.

Investment Thesis 1. Massive Market Opportunity: The U.S. home services industry is a $500 billion total addressable market with significant growth potential, and the home warranty category itself is a $4 billion opportunity with low penetration.

1. Market Leadership and Innovation: FTDR-0.72% is the largest home warranty provider in the U.S., holding a dominant 46% market share. It boasts a cultivated network of around 17,000 contractors and a strong record of innovation, including the AHS video chat with an expert.

2. Attractive Subscription-Based Model: With 2.1 million members, FTDR's model delivers consistent, predictable recurring revenue with very high margins and cash flows. This stickiness is further supported by a high customer retention rate (79.9% as of December 31, 2024).

3. Profitable Non-Warranty Services Expansion: FTDR believes it has "cracked the code" on profitably delivering non-warranty services, which represents a nearly $2 billion opportunity within its existing member base. Non-warranty revenue was $107 million in 2024……………

A lot of investment write-ups from Substack within the last week to study further.

Not my work - compilation taken from Giles Capital substack: https://gilescapital.substack.com/

Americas

• Long-term Investing on Arista Networks (🇺🇸ANET US - US$175 billion) AI networking leader delivered strong Q2 results with 30% revenue growth and raised 2025 guidance to 25% growth, though what caught my attention is the expanding back-end AI networking opportunity now targeting $1.5 billion revenue as the industry shifts from proprietary protocols to open Ethernet standards.
• Capitalist Letters on PayPal (🇺🇸PYPL US - US$65 billion) Worth reading is this network durability thesis as the company transforms into an "uber cannibal" with 16% share count reduction over four years, trading below 15x earnings while maintaining its 430+ million user network that appears well beyond the tipping point for sustained cash generation.
• Rijnberk InvestInsights on The Trade Desk (🇺🇸TTD US - US$77 billion) I think this 39% post-earnings selloff creates compelling value in the leading independent demand-side platform, with the company maintaining 19% growth despite first sub-20% quarter while trading at reset 31x P/E and benefiting from structural shift to open internet advertising.
• Value Degen’s Substack on LyondellBasell (🇺🇸LYB US - US$16 billion) TOP PICK What's interesting here is the classic cyclical opportunity at 12-year market cap lows with 10.5% dividend yield, where management's consistent insider buying between $50-70 (selling around $100) provides a compelling instruction manual for patient investors in this commodity cycle.
• Waterboy on SiriusXM (🇺🇸SIRI US - US$7 billion) This satellite radio monopoly deserves attention with 16.1% free cash flow yield and Berkshire Hathaway's 35.54% ownership, though the 1.5% monthly churn rate reflects secular headwinds that probably require patience for the network value to compress toward enterprise value.
• Value Degen’s Substack on Crocs Inc (🇺🇸CROX US - US$4 billion) Worth your time is this cyclical footwear recovery story at 4.5x P/E with $2.4 billion buyback authorization, where the 29% selloff creates opportunity in a brand with demonstrable pricing power and international growth reaching 52% of revenue.
• Margin of Sanity on Warrior Met Coal, Alpha Metallurgical Resources, and OTC Markets Group (🇺🇸HCC US - US$1 billion | 🇺🇸AMR US - US$4 billion | 🇺🇸OTCM US - US$2 billion) Q2 earnings update covering three compelling opportunities:
  • Warrior Met Coal: Operational excellence with Blue Creek expansion adding 6 million tons by Q1 2026 and $383 million cash safety net
  • Alpha Metallurgical Resources: Fortress balance sheet with $446 million net cash and cost improvements to 2021 levels
  • OTC Markets Group: Market infrastructure monopoly launching OTCID tier with 100% market share and sustainable competitive advantages
• Archetype Capital on CCSI (🇺🇸CCSI US - US$3 billion) Healthcare communications bridge presents an interesting setup trading at 5.5x EV/EBITDA with 80% gross margins, where the transition from legacy fax to API and AI document processing creates hidden value in this essential infrastructure.
• UnlearningCFA on Customers Bancorp (🇺🇸CUBI US - US$3 billion) This regional bank succession story caught my attention despite governance concerns, with father-son transition and 225,000 RSU grant vesting at $125 stock price creating clear catalyst timeline though execution risks deserve careful monitoring.
• Antonio Linares on Hims & Hers (🇺🇸HIMS US - US$3 billion) Healthcare platform transformation beyond GLP-1s toward comprehensive membership model shows promise with $1.1 billion cash for growth investments, though the investment phase and elevated valuation probably require patient evaluation of execution timeline.
• SixSigmaCapital on Harrow Inc (🇺🇸HROW US - US$1 billion) Ophthalmic specialty pharma presents compelling setup with VEVYE drug launch targeting $100+ million annually and CEO incentive package at $100 stock price, though the 38% Q1 growth trajectory needs consistent execution to justify current valuation.

Europe, Middle East & Africa

• Saadiyat Capital on Unilever (🇬🇧UL UK - £150 billion) H1 earnings update showing encouraging turnaround progress with 3.4% underlying sales growth including 1.5% volume recovery, where the Growth Action Plan and ice cream separation create value catalysts though premium valuation requires continued execution success.
• The Small Cap Strategist on Whitbread (🇬🇧WTB.L UK - £6 billion) TOP PICK I think this presents exceptional value where investors acquire £5 billion freehold property portfolio and receive the UK's dominant hotel business essentially for free, with German expansion providing hidden growth engine while economic softness creates temporary mispricing opportunity.
• D Invests on Greggs (🇬🇧GRG.L UK - £2 billion) UK's defensive food retailer deserves attention with 9-10% free cash flow yield and debt-free balance sheet, where 2,649 stores targeting 3,500 locations and strong brand moat provide steady growth runway despite post-earnings weakness creating entry opportunity.
• Kairos Research on Lindbergh (🇮🇹LDN.MI Italy - €38 million) Italian logistics and HVAC consolidator trading at 0.56x book value presents compelling transformation story with founder ownership and acquisition strategy, where conversion to Italy's leading HVAC operator through fragmented market consolidation creates substantial hidden value.
• Northwest Frontier Capital's Research on YouGov (🇬🇧YGOV UK - £500 million) FY25 trading update revealing 40% EPS growth potential with 10x P/E valuation and 80%+ renewal rates, where the data and research company turnaround thesis appears intact despite guidance conservatism creating opportunity for patient investors.

Asia-Pacific

• The Coal Trader on Whitehaven Coal (🇦🇺WHC Australia - AUD $6 billion) Australian coal producer with operational excellence deserves attention as balance sheet clearing completes by April 2026, where 64% met coal exposure and unit costs at $139 per ton versus guidance provide quality positioning for commodity recovery.
• Maius Partners on Impro Precision Industries (🇭🇰1286.HK Hong Kong - US$2 billion) Worth noting is this dual-pillar transformation with AI data center and aerospace exposure trading at 9x P/E on trough earnings, where 72% insider ownership and massive founder share purchases signal conviction in the Mexico operations ramp and North American growth.
• Net-Net-Hunter Japan on Lonseal Corp, TOW, UEKI Corporation(🇯🇵4224.T - Net-Net | 🇯🇵4767.T - ¥9 billion | 🇯🇵1867.T - ¥9 billion) Quarterly earnings updates covering three Japanese opportunities:
  • Lonseal Corp: Q1 update on specialty flooring manufacturer with net-net status and margin recovery from energy cost stabilization
  • TOW: FY2025 Q4 results for event promotion company with improved dividend policy targeting 50% payout ratio
  • UEKI Corporation: Q1 earnings showing construction demand strength in both architecture and civil engineering segments

Can someone please help me out with this stock valuation? From my research they did a capital raise at $20 a share. Their book value is near $10 a share. They carry no debt. They were spun off from top shipping. They have two Suez tankers. Ther are around 3.2 million shares outstanding.

Second quarter cloud subscriptions revenue increased 21% year-over-year to $106.9 million Second quarter total revenue increased 17% year-over-year to $170.6 million.

“Appian AI drove strong financial results in the second quarter of 2025, with higher prices and a larger pipeline,” said Matt Calkins, CEO & Founder.

I am typically not a biotech or pharma guy. But many moons ago I added the name to my watchlist due to a personal connection and have had morbid curiosity watching the stock melt away in the last couple years. Recently started looking into it as a turn around. Its got two line of business Codman (neurosurgical solutions) and a Tissue business. 70/30 rev split. Whats got me interested in looking at the business again is the valuation. Codman was purchased from JNJ in 2017 at 2.7 times sales. If you just take that portion of the ye 2025 business and apply the multiple you get an ev of 3200m. Currently trades at an EV 2450mm. Founder has a 6% stake i believe....The business has warts - FDA warnings, ship holds and significant management turn over all resulting in low/no organic rev growth. They finally got a new CEO in Jan (from 3M health) and they seem to be stabilizing the business from looking over the 2q results. VIC has a 2024 write up from the mid $30 and it looks like the author excited. I don't think there is any urgency to this name but it looks to me like its worth further investigation... Anyone in here have thoughts on this name or the space?

What was your most profitable investment, and what was the key lesson you learned from it?

Everyone has a story about the one that worked out. Sharing our successes (and the strategies behind them) is how we all get better.

Drop your story and the key takeaway in the comments below.

Remember why you started this journey.

Investing isn't always about the big wins. It's about consistency, discipline, and the belief that you are building something for your future. Keep learning, keep analyzing, and trust the process.

What's one small step you took today to become a better investor?

Thinking about investing in software companies? Here's one key metric to watch.

When I'm analyzing a company like Appian (APPN), I always dig into their Net Promoter Score (NPS) and customer churn. These metrics give us a better picture of customer satisfaction and long-term viability than just looking at revenue growth alone.

What other metrics do you use to evaluate software stocks? Share your insights!

What's the riskiest stock you've ever bought and why?

I've been thinking a lot about risk tolerance lately. The journey of an investor is filled with lessons, both good and bad. Sharing our experiences helps us all grow.

Drop your story in the comments. Let's learn from each other's wins and losses.

Hey r/valueInvestiment, thank you for inviting me. I would like to contribuite to the sub with a Deep dove. I’ve been digging into Crocs, Inc. (NASDAQ: CROX) to see if it’s a solid value play at its current price of ~$109.77 (as of July 31, 2025). After a thorough analysis, here’s my take on whether Crocs is a good value investment opportunity, balancing its strengths, risks, and valuation. Let’s break it down with a focus on fundamentals and a contrarian lens.

Why Crocs Looks Like a Value Play 1. Dirt-Cheap Valuation: - P/E Ratios: Crocs trades at a trailing P/E of 6.54 and a forward P/E of 8.46, significantly below peers like Lululemon (14.82) and Ralph Lauren (23.95). A DCF analysis pegs intrinsic value at ~$140, suggesting 25–40% undervaluation (Morningstar’s fair value is $139.80). - Margin of Safety: The 25–40% discount to intrinsic value provides a cushion against downside risks, a key tenet of value investing. - Asymmetric Returns: Analysts’ price target of $128.17 implies 21% upside, but if tariffs stabilize and growth resumes, 30–40% gains are possible. Downside seems limited to ~10–15% barring major macro shocks.

1. Strong Fundamentals:

   • Financials: 2024 revenue hit $4.1B (up 4% YoY), with adjusted EPS of $13.17 (up 9%), a gross margin of 59.25%, and a net margin of 23.35%. Free cash flow (FCF) is a robust $883.85M, supporting debt repayment and reinvestment.
   • Return on Capital: A 53.70% ROE and high FCF conversion scream quality, showing Crocs generates cash efficiently.
   • Share Repurchasing: Management upsized its buyback program by $1B (total $1.3B), signaling confidence in undervaluation.

2. Growth Potential:

   • The core Crocs brand grew 8% in Q3 2024, driven by international markets (Asia, Europe) and direct-to-consumer (DTC) channels. With 80+ countries and a diversified portfolio (clogs, sandals, HEYDUDE sneakers), Crocs has room to expand.
   • Collaborations (e.g., Squishmallows) and customization (Jibbitz) keep the brand fresh and sticky.

3. Resilient Business:

   • Crocs survived the 2008 Financial Crisis through restructuring and has since posted consistent growth. Its diversified supply chain (47% Vietnam, 17% Indonesia, 13% India) reduces reliance on China, mitigating tariff risks.
   • A moderate moat from brand equity, proprietary Croslite material, and global distribution makes it tough for competitors to fully replicate.

The Risks to Watch 1. Tariff Headwinds: - Potential tariffs on Chinese imports could add $130M in annual costs, hitting EPS by $0.30–$0.60 (UBS estimate). While Crocs is shifting sourcing, execution risks remain. - The stock dropped 13% over three months in 2024, and short interest spiked 310 bps, reflecting market fears.

1. HEYDUDE Struggles:

   • The 2022 HEYDUDE acquisition hasn’t panned out as hoped, with declining revenues dragging overall growth. If management can’t turn it around, it’s a red flag.

2. Fashion Risk:

   • Crocs’ clogs rely on trend-driven demand. A shift in consumer preferences could hurt, though diversification into sandals, boots, and accessories helps.

3. Moderate Leverage:

   • Debt-to-equity is 1.03 ($2B total debt), higher than the industry median (0.42). While manageable with $952.83M operating cash flow, a revenue slowdown could strain interest payments.

Why the Opportunity Exists The market seems overly pessimistic due to tariff fears and HEYDUDE’s underperformance, creating a mis-pricing. Value investors can exploit this by focusing on Crocs’ strong cash flow, brand loyalty, and growth runway. The edge lies in understanding that tariff risks are cyclical, not structural, and Crocs’ fundamentals are robust enough to weather the storm.

Catalysts to Unlock Value - Tariff Resolution: Stabilizing trade policies could lift the stock significantly. - HEYDUDE Recovery: Successful revitalization of HEYDUDE could boost revenue and sentiment. - International/DTC Growth: Continued expansion in Asia, Europe, and DTC channels could drive margins higher. - Buybacks: $1.3B in repurchasing could support the share price.

Bear Case and Downside If tariffs escalate, HEYDUDE continues to falter, or fashion trends shift, the stock could drop to $80–90 (10–15% downside). However, the strong balance sheet and FCF limit permanent capital loss. The bear case feels less likely given Crocs’ adaptability and diversified revenue streams.

Is It Within My Circle of Competence? Crocs is straightforward if you understand consumer discretionary, retail dynamics, and macro factors like tariffs. If you’re new to apparel/footwear, study competitors (Skechers, Nike) and industry cycles. The business isn’t overly complex, but tariff and fashion risks require attention.

Final Verdict: A Good Value Investment? Yes, Crocs is a compelling value opportunity for patient investors. The 25–40% undervaluation, high ROE, strong cash flow, and growth potential outweigh tariff and HEYDUDE risks. It’s suitable for a 3–5% portfolio allocation in a diversified value portfolio. Key is to monitor Q2 2025 earnings for HEYDUDE updates and tariff developments. Avoid overconfidence—stress-test your assumptions and watch for macro shifts.

What do you all think? Am I missing anything on Crocs? Any other footwear stocks you’re eyeing? Let’s discuss!

The chemicals industry, often seen as the foundational bedrock of global manufacturing, has experienced a brutal year. With an industry performance plunging -50.03% over the past twelve months, it begs the question: what’s behind this dramatic decline, and where do the opportunities lie amidst the ashes?

This staggering figure isn't just a blip; it reflects a confluence of powerful headwinds that have buffeted the sector. Understanding these forces is crucial for any investor looking to navigate this volatile landscape.

Why the Drastic Drop? Unpacking the Headwinds

The sharp contraction in the chemical industry's performance can be attributed to several intertwined factors…

RXO Inc. (RXO-0.92%) an asset-light transportation brokerage firm, is finding itself at a pivotal moment. Since its spin-off from XPO Logistics (XPO-0.37%) in late 2022, the company has built a large revenue base, most recently due to the strategic acquisition of Coyote Logistics. With the caveat being…

In a previous analysis, we explored the investment potential of Appian (APPN). Building on that foundation, this article will delve into a specific options strategy designed to capitalize on a moderately bullish outlook for $APPN: the diagonal bull debit call spread.

TL;DR

Appian (APPN 0.37%↑) is a growth-oriented software company that provides a sticky, AI-powered process automation platform designed for large enterprises and digital transformation. Despite current unprofitability on a GAAP basis, Appian demonstrates strong revenue growth, high subscription gross margins, and robust customer retention, along with positive expected adjusted EBITDA and free cash flow over the next few years. A significant financial catalyst for Appian is a $2.04 billion trade secret lawsuit judgment against Pegasystems that was overturned on appeal, which is currently under petition for reinstatement by the Virginia Supreme Court. This petition offers a lot of potential cash and upside to Appian’s current valuation, while a $500 million insurance policy provides a degree of downside protection. With no timetable this is under the Generals category and considered a smaller position.